Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Importin subunit beta-1 (KPNB1) is a key protein in the nuclear import pathway. It mediates the transport of proteins from the cytoplasm into the nucleus through nuclear pore complexes (NPCs). It forms a heterodimer with importin alpha to recognize cargo proteins containing nuclear localization signals (NLS) and docks this complex at the cytoplasmic side of NPCs. KPNB1 is overexpressed in some cancers, making it a potential therapeutic target. Inhibition disrupts proteostasis and triggers apoptosis.
Inhibition of KPNB1 disrupts nuclear import, leading to cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Importin Subunit Beta 1.